中文(简体)/Chinese Simplified
Chinese medicine for weight loss
Shenyi Center of Chinese medicine has a variety of Chinese medicines for weight loss click here

Chinese Medicine Category
Recommended Product
Da Yin Xiang Jian Fei Cha
chinese medicine for weight loss


Great Impression Weight Reducing Tea or Great Image Weight Loss Tea, also known as
Da Yin Xiang Jian Fei Cha or jLH减ί

Da Yin Xiang Jian Fei Cha is effectively reducing weight, decreasing lipids in blood, preventing acquired simple obesity. Probably the best of natural weight loss products presented on Chinese market.

Direction for use A sachet of the tea is soaked in approx 170ml of boiled water for 5-10 minutes, this can be done for two times in a row. At first, it is most appropriate to drink before sleeping,
one sachet every evening in the first week, each in the morning and evening from the second week, and 45 days is the course of use.

Manufacturer: Shantou Great Impression Group

Chinese Slimming Tea Bishengyuan
chinese slimming tea for weight loss


Slimming Bishengyuan tea for weight loss is one of the most popular and effective weight loss herbal tea on Chinese market recently. It can significantly reduce subcutaneous fat, waistline and the length of breech.

After drinking Chinese Slimming Bishengyuan Tea for the first time, you can feel its effectiveness the same day. The tea reduces weight thoroughly and entirely, improving obesity physique.

A sachet of the tea every morning and evening, each time 1-2 sachets Keep out of reach from children.
Do not use during pregnancy.
The net weight is 50g, 2.5g* 20 sachets per box
Manufacturer: Beijing Outsell Health Product Development Co., Ltd.

Chinese medicine for weight loss research

Metabolic effects of green tea and of phases of weight loss.
Diepvens K, Kovacs EM, Vogels N, Westerterp-Plantenga MS.
Maastricht University, Department of Human Biology, P.O. Box 616 NL-6200 MD, Maastricht, The Netherlands. K.Diepvens at HB.Unimaas.NL
The effect of ingestion of green tea (GT) extract along with a low-energy diet (LED) on health-related blood parameters, and the relationships among changes in metabolic parameters and phases of weight loss were assessed. A double-blind, placebo-controlled, parallel design was used. 46 female subjects (BMI 27.7+/-1.8 kg/m(2)) were fed in energy balance from days 1 to 3, followed by a LED with GT (n=23) or placebo (PLAC, n=23) from days 4 to 87. The LED-period consisted of a phase 1 of 4 weeks (days 4-32) followed by a phase 2 of 8 weeks (days 32-87). Body composition and fasting blood samples were determined on days 4, 32 and 87. No significant differences were observed between the blood parameters of the PLAC and GT group. In phase 1 compared to phase 2 the rate of weight loss was 0.09+/-0.05 kg/day vs. 0.03+/-0.03 kg/day (p<0.001); Fat free mass (FFM) was 21% of weight loss in phase 1 vs. 7% in phase 2 (ns). Surprisingly, favourable changes in free fatty acids, triacylglycerol, beta-hydroxybutyrate, glucose and total cholesterol in phase 1 were reversed in phase 2 (p<0.01). Taken together, GT supplementation during a LED had no effect on health-related blood parameters. Initial improvements in several blood measures at day 32 were reversed by day 87, despite continued weight loss. Modest weight loss improved HDL cholesterol and blood pressure.

Anti-obesity drug use before professional treatment in Taiwan.
Liou TH, Wu CH, Chien HC, Lin WY, Lee WJ, Chou P.
Community Medicine Research Center and Institute of Public Health, National Yang Ming University, Peitou, Taipei, Taiwan.
Between July 2004 and June 2005, a cross-sectional study was performed to determine the prevalence and patterns of anti-obesity medicine use among subjects seeking obesity treatment in Taiwan. Eighteen obesity outpatient clinics were selected via a random stratified sampling method and 1,060 first-visit clients (791 females and 269 males) aged above 18 years were enrolled and then completed a self-administered questionnaire. The prevalence of anti-obesity medicine use was 50.8%; more females than male used anti-obesity medicines (53.6% vs. 42.4%). Of the 1,060 subjects, 17.1% had used orlistat, 21.1% had taken sibutramine, and 18.3% had utilized un-proven drugs such as cocktail therapy and other anti-obesity drugs. Furthermore, 23.6% and 22.4% of subjects indicated that they concurrently used Chinese herbal preparations and dietary supplements, respectively. Logistic regression analyses demonstrated that the odds ratio (OR) for anti-obesity medicine use was substantially higher in females (OR, 1.9; 95% CI, 1.3-2.6), those aged 18-24 years (OR, 1.6; 95% CI, 1.0-2.6), those with a body mass index (BMI) >35 kg/m2 (OR, 3.4; 95% CI, 2.1-5.7) and respondents concurrently using Chinese herbal preparations (OR, 1.7; 95% CI, 1.2-2.4) and dietary supplements (OR, 2.2; 95% CI, 1.6-3.1). In conclusion, the prevalence of anti-obesity drugs use is high among Taiwanese adults before they seek obesity treatment. Young, obese females, and those who had taken Chinese herbal preparations/dietary supplements had a high likelihood to report using anti-obesity medicines. Use of unproven weight-loss drugs is common and warrants further investigation.

This is the page for Chinese medicine for weight loss